Oak Harvest Investment Services’s West Pharmaceutical WST Stock Holding History

Oak Harvest Investment Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	+3,500	New	+$1.07M	0.12%	103

Other funds holding WST

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Ninety One (UK)

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Oak Harvest Investment Services's WST Position: Q2 2026 in Review

Oak Harvest Investment Services opened a new position in West Pharmaceutical (WST) in Q2 2026: 3,500 shares worth $1.26M. The stake represents 0.12% of the portfolio and ranks #103 among its holdings.

199 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Oak Harvest Investment Services held 3,500 shares of West Pharmaceutical worth $1.26M as of Q2 2026.
West Pharmaceutical was a new Oak Harvest Investment Services position in Q2 2026.
West Pharmaceutical made up 0.12% of Oak Harvest Investment Services's portfolio in Q2 2026, its #103 holding.
199 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Oak Harvest Investment Services's 13F filing for Q2 2026, filed 27 Jul 2026.